Identification of a novel recurrent 1q42.2-1qter deletion in high risk MYCN single copy 11q deleted neuroblastomas

被引:39
作者
Fieuw, Annelies [1 ]
Kumps, Candy [1 ]
Schramm, Alexander [2 ]
Pattyn, Filip [1 ]
Menten, Bjorn [1 ]
Antonacci, Francesca [3 ]
Sudmant, Peter [3 ]
Schulte, Johannes H. [2 ]
Van Roy, Nadine [1 ]
Vergult, Sarah [1 ]
Buckley, Patrick G. [4 ,5 ,6 ]
De Paepe, Anne [1 ]
Noguera, Rosa [7 ]
Versteeg, Rogier [8 ]
Stallings, Raymond [4 ,5 ]
Eggert, Angelika [2 ]
Vandesompele, Jo [1 ]
De Preter, Katleen [1 ]
Speleman, Frank [1 ]
机构
[1] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium
[2] Univ Childrens Hosp Essen, Dept Pediat Oncol & Haematol, Essen, Germany
[3] Univ Washington, Dept Genome Sci, Eichler Lab, Seattle, WA 98195 USA
[4] Our Ladys Childrens Hosp, Royal Coll Surg Ireland, Dept Canc Genet, Dublin, Ireland
[5] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland
[6] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin 2, Ireland
[7] Univ Valencia, Sch Med, Dept Pathol, Valencia, Spain
[8] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands
基金
加拿大自然科学与工程研究理事会; 爱尔兰科学基金会;
关键词
neuroblastoma; array CGH; chromosome; 1; deletion; EXPRESSION; SUBGROUPS; NUMBER; GENES; CLASSIFICATION; MUTATIONS; PHENOTYPE; PROFILES; BREAST; TUMORS;
D O I
10.1002/ijc.26317
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neuroblastoma is an aggressive embryonal tumor that accounts for similar to 15% of childhood cancer deaths. Hitherto, despite the availability of comprehensive genomic data on DNA copy number changes in neuroblastoma, relatively little is known about the genes driving neuroblastoma tumorigenesis. In this study, high resolution array comparative genome hybridization (CGH) was performed on 188 primary neuroblastoma tumors and 33 neuroblastoma cell lines to search for previously undetected recurrent DNA copy number gains and losses. A new recurrent distal chromosome 1q deletion (del(1)(q42.2qter)) was detected in seven cases. Further analysis of available array CGH datasets revealed 13 additional similar distal 1q deletions. The majority of all detected 1q deletions was found in high risk 11q deleted tumors without MYCN amplification (Fisher exact test p = 5.61 x 10-5). Using ultra-high resolution (similar to 115 bp resolution) custom arrays covering the breakpoints on 1q for 11 samples, clustering of nine breakpoints was observed within a 12.5-kb region, of which eight were found in a 7-kb copy number variable region, whereas the remaining two breakpoints were colocated 1.4-Mb proximal. The commonly deleted region contains one miRNA (hsa-mir-1537), four transcribed ultra conserved region elements (uc.43-uc.46) and 130 protein coding genes including at least two bona fide tumor suppressor genes, EGLN1 (or PHD2) and FH. This finding further contributes to the delineation of the genomic profile of aggressive neuroblastoma, offers perspectives for the identification of genes contributing to the disease phenotype and may be relevant in the light of assessment of response to new molecular treatments.
引用
收藏
页码:2599 / 2606
页数:8
相关论文
共 31 条
[21]   Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations [J].
Pollard, PJ ;
Brière, JJ ;
Alam, NA ;
Barwell, J ;
Barclay, E ;
Wortham, NC ;
Hunt, T ;
Mitchell, M ;
Olpin, S ;
Moat, SJ ;
Hargreaves, IP ;
Heales, SJ ;
Chung, YL ;
Griffiths, JR ;
Dalgleish, A ;
McGrath, JA ;
Gleeson, MJ ;
Hodgson, SV ;
Poulsom, R ;
Rustin, P ;
Tomlinson, IPM .
HUMAN MOLECULAR GENETICS, 2005, 14 (15) :2231-2239
[22]   The consensus coding sequences of human breast and colorectal cancers [J].
Sjoeblom, Tobias ;
Jones, Sian ;
Wood, Laura D. ;
Parsons, D. Williams ;
Lin, Jimmy ;
Barber, Thomas D. ;
Mandelker, Diana ;
Leary, Rebecca J. ;
Ptak, Janine ;
Silliman, Natalie ;
Szabo, Steve ;
Buckhaults, Phillip ;
Farrell, Christopher ;
Meeh, Paul ;
Markowitz, Sanford D. ;
Willis, Joseph ;
Dawson, Dawn ;
Willson, James K. V. ;
Gazdar, Adi F. ;
Hartigan, James ;
Wu, Leo ;
Liu, Changsheng ;
Parmigiani, Giovanni ;
Park, Ben Ho ;
Bachman, Kurtis E. ;
Papadopoulos, Nickolas ;
Vogelstein, Bert ;
Kinzler, Kenneth W. ;
Velculescu, Victor E. .
SCIENCE, 2006, 314 (5797) :268-274
[23]   Diversity of Human Copy Number Variation and Multicopy Genes [J].
Sudmant, Peter H. ;
Kitzman, Jacob O. ;
Antonacci, Francesca ;
Alkan, Can ;
Malig, Maika ;
Tsalenko, Anya ;
Sampas, Nick ;
Bruhn, Laurakay ;
Shendure, Jay ;
Eichler, Evan E. .
SCIENCE, 2010, 330 (6004) :641-646
[24]   Erlotinib in lung cancer - Molecular and clinical predictors of outcome [J].
Tsao, MS ;
Sakurada, A ;
Cutz, JC ;
Zhu, CQ ;
Kamel-Reid, S ;
Squire, J ;
Lorimer, I ;
Zhang, T ;
Liu, N ;
Daneshmand, M ;
Marrano, P ;
Santos, GD ;
Lagarde, A ;
Richardson, F ;
Seymour, L ;
Whitehead, M ;
Ding, KY ;
Pater, J ;
Shepherd, FA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :133-144
[25]   Smoothing waves in array CGH tumor profiles [J].
van de Wiel, Mark A. ;
Brosens, Rebecca ;
Eilers, Paul H. C. ;
Kumps, Candy ;
Meijer, Gerrit A. ;
Menten, Bjorn ;
Sistermans, Erik ;
Speleman, Frank ;
Timmerman, Marieke E. ;
Ylstra, Bauke .
BIOINFORMATICS, 2009, 25 (09) :1099-1104
[26]   Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH [J].
Van Limbergen, H ;
Poppe, B ;
Michaux, L ;
Herens, C ;
Brown, J ;
Noens, L ;
Berneman, Z ;
De Bock, R ;
De Paepe, A ;
Speleman, F .
GENES CHROMOSOMES & CANCER, 2002, 33 (01) :60-72
[27]   Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma [J].
Van Maerken, Tom ;
Speleman, Frank ;
Vermeulen, Joelle ;
Lambertz, Irina ;
De Clercq, Sarah ;
De Smet, Els ;
Yigit, Nurten ;
Coppens, Vicky ;
Philippe, Jan ;
De Paepe, Anne ;
Marine, Jean-Christophe ;
Vandesompele, Jo .
CANCER RESEARCH, 2006, 66 (19) :9646-9655
[28]   Analysis of 1;17 translocation breakpoints in neuroblastoma: Implications for mapping of neuroblastoma genes [J].
Van Roy, N ;
Laureys, G ;
Van Gele, M ;
Opdenakker, G ;
Miura, R ;
van der Drift, P ;
Chan, A ;
Versteeg, R ;
Speleman, F .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (12) :1974-1978
[29]   The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy [J].
Van Roy, Nadine ;
De Preter, Katleen ;
Hoebeeck, Jasmien ;
Van Maerken, Tom ;
Pattyn, Filip ;
Mestdagh, Pieter ;
Vermeulen, Joelle ;
Vandesompele, Jo ;
Speleman, Frank .
GENOME MEDICINE, 2009, 1
[30]   PHF6 mutations in T-cell acute lymphoblastic leukemia [J].
Van Vlierberghe, Pieter ;
Palomero, Teresa ;
Khiabanian, Hossein ;
Van der Meulen, Joni ;
Castillo, Mireia ;
Van Roy, Nadine ;
De Moerloose, Barbara ;
Philippe, Jan ;
Gonzalez-Garcia, Sara ;
Toribio, Maria L. ;
Taghon, Tom ;
Zuurbier, Linda ;
Cauwelier, Barbara ;
Harrison, Christine J. ;
Schwab, Claire ;
Pisecker, Markus ;
Strehl, Sabine ;
Langerak, Anton W. ;
Gecz, Jozef ;
Sonneveld, Edwin ;
Pieters, Rob ;
Paietta, Elisabeth ;
Rowe, Jacob M. ;
Wiernik, Peter H. ;
Benoit, Yves ;
Soulier, Jean ;
Poppe, Bruce ;
Yao, Xiaopan ;
Cordon-Cardo, Carlos ;
Meijerink, Jules ;
Rabadan, Raul ;
Speleman, Frank ;
Ferrando, Adolfo .
NATURE GENETICS, 2010, 42 (04) :338-U95